Adams P C, Chau L A
Department of Medicine, University Hospital, University of Western Ontario, London.
Clin Invest Med. 1993 Feb;16(1):15-21.
To further characterize the hepatic endocytic pathway of ferritin, the effects of inhibitors of intracellular dissociation of ligands (monensin 15 microM, chloroquine 400 microM), intracellular proteolysis (leupeptin 100 microM) and iron loading on the endocytosis of 125I-rat liver ferritin were studied in isolated rat hepatocytes. Cell associated radioactivity at 37 degrees C was decreased by 27% with chloroquine and 18% with monensin after 4 h. Cell associated radioactivity increased by 38% with leupeptin at 37 degrees C. Acid soluble radioactivity in the extracellular medium was significantly decreased at 4 h in the leupeptin group, which suggests that leupeptin inhibited the lysosomal degradation of the 125I-ferritin resulting in intracellular accumulation of ligand rather than increased uptake of ferritin. Iron loading of cells (5.4-fold increase in intracellular iron) did not significantly alter the binding or accumulation of 125I-ferritin. The characteristics of the endocytic pathway for ferritin are more similar to the asialoglycoprotein receptor than the transferrin receptor, and the hepatic uptake of ferritin is unaffected in this study by increasing the intracellular iron concentration.
为了进一步表征铁蛋白的肝内吞途径,在分离的大鼠肝细胞中研究了配体胞内解离抑制剂(莫能菌素15微摩尔、氯喹400微摩尔)、胞内蛋白水解抑制剂(亮抑酶肽100微摩尔)和铁负载对125I-大鼠肝脏铁蛋白内吞作用的影响。4小时后,氯喹使37℃下细胞相关放射性降低27%,莫能菌素使其降低18%。亮抑酶肽在37℃下使细胞相关放射性增加38%。亮抑酶肽组细胞外培养基中的酸溶性放射性在4小时时显著降低,这表明亮抑酶肽抑制了125I-铁蛋白的溶酶体降解,导致配体在细胞内积累,而不是铁蛋白摄取增加。细胞铁负载(细胞内铁增加5.4倍)并未显著改变125I-铁蛋白的结合或积累。铁蛋白内吞途径的特征与去唾液酸糖蛋白受体比转铁蛋白受体更相似,并且在本研究中,增加细胞内铁浓度未影响肝脏对铁蛋白的摄取。